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Risk prediction algorithms are an important tool for
identifying individuals at high risk of developing the dis-
ease who can then be offered individually tailored clini-
cal management. Several algorithms that predict the
probability of breast cancer incidence are currently used
in clinical practice. It is uncertain, though, as to which
of the breast cancer risk prediction models performs
best for female relatives of Australian women with
breast cancer.
We evaluated the performance of the risk prediction
algorithms BOADICEA, BRCAPRO and the Gail model
using 879 families of ABCFS case probands, half of
whom were diagnosed before age 40 years and the
remainder before age 60 years. Cumulative breast cancer
risks over 10 years of follow-up were calculated for 2000
unaffected female relatives.
A total of 93 incident breast cancers were reported.
The ratios (95% CI) of expected to observed number of
breast cancers were 0.69 (0.56-0.84) using BOADICEA,
0.62 (0.51-0.77) using BRCAPRO, and 0.89 (0.73-1.09)
using the Gail model. Tests for discrimination (ROC
curve) were BOADICEA=0.61, BRCAPRO=0.64, and the
Gail model=0.65.
Similar analyses using other models, including the
Tyrer-Cuzick (IBIS) and Claus models, will also be
presented.
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